syringaresinol has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
| Adlercreutz, H; Ignace, G; Joffe, R; Krams, I; Lejnieks, A; Lietuvietis, V; Meija, L; Samaletdin, A; Siksna, I; Söderholm, P | 1 |
| Awale, S; Kadota, S; Li, F; Tezuka, Y | 1 |
1 review(s) available for syringaresinol and Neoplasms
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
2 other study(ies) available for syringaresinol and Neoplasms
| Article | Year |
|---|---|
Dietary intake and major sources of plant lignans in Latvian men and women.
Topics: Adult; Aged; Bread; Butylene Glycols; Cardiovascular Diseases; Diet; Feeding Behavior; Female; Flax; Furans; Humans; Latvia; Lignans; Male; Middle Aged; Neoplasms; Phenols; Phytoestrogens; Plant Extracts; Sex Factors | 2013 |
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
Topics: Animals; Brazil; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavanones; Flavonoids; HeLa Cells; Humans; Inhibitory Concentration 50; Mice; Molecular Structure; Neoplasms; Propolis; Stereoisomerism; Structure-Activity Relationship | 2008 |